| |
| |
|
| Insider
Information: |
Drachman Jonathan G |
| Relationship: |
|
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
2,750,659 |
|
|
Indirect Shares
|
25,000 |
|
|
| Direct
Value |
$54,846,469 |
|
|
|
Indirect Value
|
$92,000 |
|
|
| Total
Shares |
2,775,659 |
|
|
| Total
Value |
$54,938,469 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -80.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
CMO & EVP, R & D |
2018-03-20 |
201,973 |
|
0 |
Premium* |
|
|
Neurogene |
NGNE |
President and CEO, Dir... |
2021-08-24 |
2,348,686 |
2021-08-25 |
25,000 |
Premium* |
|
|
Calithera Biosciences, Inc. |
CALA |
Director |
2021-11-10 |
200,000 |
2021-11-10 |
0 |
Premium* |
|
|
Harpoon Therapeutics, Inc. |
HARP |
|
2024-03-11 |
0 |
2023-11-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HARP |
Harpoon Therapeutics, Inc... |
|
– • – |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,415) |
0 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
|
– • – |
2024-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
415 |
5,415 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • – |
2023-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
Director |
– • – |
2021-11-10 |
4 |
B |
$0.86 |
$171,900 |
D/D |
200,000 |
200,000 |
2.39 |
% |
|
| NGNE |
Neurogene |
President and CEO |
• • – |
2021-08-25 |
4 |
B |
$6.45 |
$322,450 |
I/I |
50,000 |
25,000 |
2.66 |
- |
|
| NGNE |
Neurogene |
President and CEO |
• • – |
2021-08-24 |
4 |
B |
$6.11 |
$611,100 |
D/D |
100,000 |
2,348,686 |
2.81 |
- |
|
| NGNE |
Neurogene |
President and CEO |
• • – |
2021-06-04 |
4 |
B |
$9.61 |
$96,082 |
D/D |
10,000 |
2,248,686 |
2.81 |
- |
|
| NGNE |
Neurogene |
President and CEO |
• • – |
2021-06-03 |
4 |
B |
$9.48 |
$379,272 |
D/D |
40,000 |
2,238,686 |
2.81 |
- |
|
| NGNE |
Neurogene |
President and CEO |
• • – |
2019-12-20 |
4 |
B |
$8.40 |
$999,995 |
D/D |
119,047 |
2,198,686 |
2.81 |
- |
|
| NGNE |
Neurogene |
President and CEO |
• • – |
2019-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,261,600 |
2,079,639 |
0 |
- |
|
| NGNE |
Neurogene |
President and CEO |
• • – |
2019-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,616 |
0 |
0 |
- |
|
| NGNE |
Neurogene |
See Remarks |
• • – |
2019-09-11 |
4 |
B |
$3.30 |
$449,898 |
D/D |
136,436 |
584,428 |
2.81 |
- |
|
| NGNE |
Neurogene |
See Remarks |
• • – |
2019-09-10 |
4 |
B |
$3.08 |
$113,290 |
D/D |
36,742 |
447,992 |
2.81 |
- |
|
| NGNE |
Neurogene |
See Remarks |
• • – |
2019-09-09 |
4 |
B |
$2.85 |
$218,559 |
D/D |
76,822 |
411,250 |
2.81 |
- |
|
| NGNE |
Neurogene |
President and CEO |
• • – |
2019-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
334,428 |
334,428 |
0 |
- |
|
| NGNE |
Neurogene |
President and CEO |
• • – |
2019-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,428 |
7,428 |
0 |
- |
|
| NGNE |
Neurogene |
See Remarks |
• • – |
2019-08-08 |
4/A |
A |
$0.00 |
$0 |
D/D |
568,039 |
568,039 |
0 |
- |
|
| NGNE |
Neurogene |
See Remarks |
• • – |
2019-08-08 |
4/A |
A |
$0.00 |
$0 |
D/D |
12,616 |
12,616 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2018-03-20 |
4 |
OE |
$10.61 |
$439,134 |
D/D |
31,039 |
201,973 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2018-03-05 |
4 |
AS |
$52.70 |
$552,452 |
D/D |
(10,457) |
170,934 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2018-03-05 |
4 |
OE |
$8.96 |
$93,695 |
D/D |
10,457 |
174,191 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2018-01-11 |
4 |
OE |
$10.61 |
$214,705 |
D/D |
19,416 |
170,934 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2017-10-05 |
4 |
OE |
$10.61 |
$205,253 |
D/D |
17,816 |
151,518 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2017-08-28 |
4 |
AS |
$47.89 |
$407,199 |
D/D |
(8,502) |
133,702 |
0 |
- |
|
| SGEN |
Seagen Inc |
CMO & EVP, R & D |
• – – |
2017-08-24 |
4 |
AS |
$47.54 |
$475,414 |
D/D |
(10,000) |
142,204 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
